CYP1A1 and CYP3A4 modulation by dietary flavonoids in human intestinal Caco-2 cells

Toxicology Letters

Volumn 191, Issue 2-3, 2009, Pages 216-222

  Sergent, Thérèse ^a   Dupont, Isabelle ^a   Van Der Heiden, Edwige ^b   Scippo, Marie Louise ^b   Pussemier, Luc ^c   Larondelle, Yvan ^a   Schneider, Yves Jacques ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

Author keywords

CYP1A1; CYP3A4; EROD assay; Food and drug interactions; Human intestinal Caco 2 cells; Polyphenols

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CALCITRIOL; CATECHIN; CHRYSIN; CYTOCHROME P450 1A1; CYTOCHROME P450 3A4; ELLAGIC ACID; EPIGALLOCATECHIN GALLATE; ETHOXYRESORUFIN DEETHYLASE; FLAVONOID; GENISTEIN; NARINGENIN; QUERCETIN; RESVERATROL;

ARTICLE; CANCER PREVENTION; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; ENZYME INHIBITION; FOOD DRUG INTERACTION; FOOD SAFETY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEALTH HAZARD; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

CACO-2 CELLS; CALCITRIOL; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP3A; DIET; DIPEPTIDYL PEPTIDASE 4; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; ENZYME INDUCTION; ENZYME INHIBITORS; FLAVONOIDS; GENISTEIN; HUMANS; INTESTINES; QUERCETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STILBENES; TETRACHLORODIBENZODIOXIN;

EID: 70449701477     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.09.002     Document Type: Article

References (66)

1. Agullo G., Gamet-Payrastre L., Manenti S., Viala C., Remesy C., Chap H., and Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol. 1 (1997) 1649-1657
2. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., and Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262 (1987) 5592-5595
3. Ashida H. Suppressive effects of flavonoids on dioxin toxicity. BioFactors 12 (2000) 201-206
4. Ashida H., Fukuda I., Yamashita T., and Kanazawa K. Flavones and flavanols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS Lett. 476 (2000) 213-217
5. Baugmart A., Schmidt M., Schmitz H.J., and Schrenk D. Natural furocoumarins as inducers and inhibitors of cytochrome P450 1A1 in rat hepatocytes. Biochem. Pharmacol. 69 (2005) 657-667
6. Berger V., Gabriel A.F., Sergent T., Trouet A., Larondelle Y., and Schneider Y.J. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP-2). Toxicol. Lett. 140/141 (2003) 465-476
7. Boulenc X., Bourrie M., Fabre I., Roque C., Joyeux H., Berger Y., and Fabre G. Regulation of cytochrome P4501A1 gene expression in a human intestinal cell line, Caco-2. J. Pharm. Exp. Ther. 263 (1992) 1471-1478
8. Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 56 (1998) 317-333
9. Burke M., Thompson S., Weaver R., Wolf C., and Mayer R. Cytochrome P450 specificities of alkoresorufin O-dealkylation in human and rat liver. Biochem. Pharmacol. 48 (1994) 923-926
10. Cermak R., and Wolffram S. The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms. Curr. Drug Metab. 7 (2006) 729-744
11. Chantret I., Rodolosse A., Barbat A., Dussaulx E., Brot-Laroche E., Zweibaum A., and Rousset M. Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J. Cell Sci. 107 (1994) 213-225
12. Ciolino H., Daschner P., and Yeh G. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J. 340 (1999) 715-722
13. Ciolino H., Wang T., and Yeh G. Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer Res. 58 (1998) 2754-2760
14. Decker T., and Lohmann-Matters M.L. A quick and simple method for the quantification of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods 15 (1988) 61-69
15. De Waard P., de Kok T., Maas L., Peijnenburg A., Hoogenboom R., Aarts J., and van Schooten F. Influence of TCDD and natural Ah receptor agonists on benzo(a)pyrene-DNA adduct formation in the Caco-2 human colon cell line. Mutagenesis 23 (2008) 67-73
16. Ding X., and Kaminsky L. Human extrahepatic cytochrome P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 149-173
17. Donovan J., Chavin K., Devane C., Taylor R., Wang J.S., Ruan Y., and Markowitz J. Green tea (Camellia sinensis) extract does not alter cytochrome P450 3A4 or 2D6 activity in healthy volunteers. Drug Metab. Dispos. 32 (2004) 906-908
18. Edwards D., Fitzsimmons M., Schuetz E., Yasuda K., Ducharme M., Warbasse L., Woster P., Schuetz J., and Watkins P. 6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin. Pharmacol. Ther. 65 (1999) 237-244
19. Fuhr U. Drug interactions with grapefruit juice. Extent probable mechanism and clinical relevance. Drug Saf. 18 (1998) 251-272
20. Gibbs M., Thummel K., Shen D., and Kunze K. Inhibition of CYP3A in human intestinal and liver microsomes: Comparison of Ki values and impact of CYP3A5 expression. Drug Metab. Dispos. 27 (1999) 180-187
21. Hara H., Yasunami Y., and Adachi T. Alteration of cellular phosphorylation state affects vitamin D receptor-mediated CYP3A4 mRNA induction in Caco-2 cells. Biochem. Biophys. Res. Commun. 296 (2002) 182-188
22. Hebert M., Roberts J., Prueksaritanont T., and Benet L. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin. Pharmacol. Ther. 52 (1992) 453-457
23. Helsby N., Williams J., Kerr D., Gescher A., and Chipman J. The isoflavones equol and genistein do not induce xenobiotic-metabolizing enzymes in mouse and in human cells. Xenobiotica 27 (1997) 587-596
24. Ito S., Chen C., Satoh J., Yim S.H., and Gonzalez F. Dietary phytochemicals regulate whole-body CYP1A1 expression through an arylhydrocarbon receptor nuclear translocator-dependent system in gut. J. Clin. Invest. 117 (2007) 1940-1950
25. Jeuken A., Keser B., Khan E., Brouwer A., Koeman J., and Denison M. Activation of the Ah receptor by extracts of dietary herbal supplements, vegetables, and fruits. J. Agric. Food Chem. 51 (2003) 5478-5487
26. Le Ferrec E., Chesne C., Artusson P., Brayden D., Fabre G., Gires P., Guillou F., Rousset M., Rubas W., and Scarino M.-L. In vitro models of the intestinal barrier. ATLA 29 (2001) 649-668
27. Lin J.H. CYP induction-mediated drug interactions: in vitro assessment and clinical implications. Pharm. Res. 23 (2006) 1089-1116
28. Lown K., Bailey D., Fontana R., Janardan S., Adair C., Fortlage L., Brown M., Guo W., and Watkins P. Grapefruit juice increases felodipine oral bioavailability in humans by decreasing intestinal CYP3A protein expression. J. Clin. Invest. 99 (1997) 2545-2553
29. Manach C., Scalbert A., Morand C., Rémésy C., and Jimenez L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79 (2004) 727-747
30. Mandal P. Dioxin: a review of its environment effects and its aryl hydrocarbon receptor biology. J. Comp. Physiol. B 175 (2005) 221-230
31. Mandlekar S., Hong J.L., and Kong A.H.T. Modulation of metabolic enzymes by dietary phytochemicals: a review of mechanisms underlying beneficial versus unfavorable effects. Curr. Drug Metab. 7 (2006) 661-675
32. McKinnon R., Burgess W., Hall P., Abdul-Aziz Z., and McMannus M. Metabolism of food-derived heterocyclic amines in human and rabbit tissues by P4503A proteins in the presence of flavonoids. Cancer Res. 52 (1992) 2108S-2113S
33. McKinnon R., Burgess W., Hall P., Roberts-Thomson S., Gonzalez F., and McMannus M. Characterization of CYP3A gene subfamily expression in human gastrointestinal tissues. Gut 36 (1995) 259-267
34. Murray M. Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. Curr. Drug Metab. 7 (2006) 67-81
35. Nagatsu T., Hino M., Fuyamada T., Hayakawa T., Sakakibara S., Nakagawa Y., and Takemoto T. New chromogenic substrates for X-prolyl dipeptidyl aminopeptidase. Anal. Biochem. 74 (1976) 466-476
36. Nebert D., Dalton T., Okey A., and Gonzalez F. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279 (2004) 23847-23850
37. Netsch M., Gutman H., Schmidlin C., Aydogan C., and Drewe J. Induction of CYP1A by green tea extract in human intestinal cell lines. Planta Med. 72 (2006) 514-520
38. Nowack R. Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: Grapefruit juice, St John's Wort - and beyond!. Nephrology 13 (2008) 337-347
39. Paine M., Hart H., Ludington S., Haining R., Rettie A., and Zeldin D. The human intestinal cytochrome P450 « Pie ». Drug Metab. Dispos. 34 (2006) 880-886
40. Paine M., Shen D., Kunze K., Perkins J., Marsh C., McVicar J., Barr D., Gillies B., and Thummel K. First-pass metabolism of midazolam by the human intestine. Clin. Pharmacol. 60 (1996) 14-24
41. Pavek P., and Dvorak Z. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human exraheptic tissues. Curr. Drug Metab. 9 (2008) 129-143
42. Pelkonen O., Turpeinen M., Hakkola J., Honkakovski P., Hukkanen J., and Raunio H. Inhibition and induction of human cytochrome P450 enzymes: current status. Arch. Toxicol. 82 (2008) 667-715
43. Pohl C., Will F., Dietrich H., and Schrenk D. Cytochrome P450 1A1 expression and activity in Caco-2 cells: modulation by apple juice extract and certain apple polyphenols. J. Agric. Food Chem. 54 (2006) 10262-10268
44. Porter T., and Coon M. Cytochrome P450: multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J. Biol. Chem. 266 (1991) 13469-13472
45. Rapaka R., and Coates P. Dietary supplements and related products: a brief summary. Life Sci. 78 (2006) 2026-2032
46. Roberts B., Song B.J., Sohn Y., Park S., and Shoaf S. Ethanol induces CYP2E1 by protein stabilization. J. Biol. Chem. 270 (1995) 29632-29635
47. Rodeiro I., Donato M., Lahoz A., Garrido G., Delgado R., and Gomez-Lechon M. Interactions of polyphenols with the P450 system: possible implications on human therapeutics. Mini-Rev. Med. Chem. 8 (2008) 97-106
48. Romier B., Van de Walle J., During A., Larondelle Y., and Schneider Y.J. Modulation of signaling nuclear factor-κB activation pathway by polyphenols in human intestinal Caco-2 cells. Br. J. Nutr. 100 (2008) 42-551
49. Romier-Crouzet B., Van de Walle J., During A., Joly A., Rousseau C., Henry O., Larondelle Y., and Schneider Y.J. Inhibition of inflammatory mediators by polyphenolic plant extracts in human intestinal cells. Food Chem. Toxicol. 47 (2009) 1221-1230
50. Scalbert A., Manach C., Morand C., Remesy C., and Jimenez L. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 45 (2005) 287-306
51. Schmiedlin-Ren P., Edwards D., Fitzsimmons M., Kan H., Lown K., Woster P., Rahman A., Thummel K., Fisher J., Hollenberg P., and Watkins P. Mechanisms of enhanced oral bioavailability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab. Dispos. 25 (1997) 1228-1233
52. Sergent-Engelen T., Delistrie V., and Schneider Y.J. Phase I and II biotransformations in living Caco-2 cells cultivated under serum-free conditions. Biochem. Pharmacol. 46 (1993) 1393-1401
53. Sergent T., Dupont I., Jassogne C., Ribonnet L., Van der Heiden E., Scippo M.L., Muller M., Mc Alister D., Pussemier L., Larondelle Y., and Schneider Y.J. CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-comparison with other conazole pesticides. Toxicol. Lett. 184 (2009) 159-168
54. Sergent T., Garsou S., Schaut A., De Saeger S., Pussemier L., Van Peteghem C., Larondelle Y., and Schneider Y.J. Differential modulation of ochratoxin A absorption across Caco-2 cells by dietary polyphenols, used at realistic intestinal concentrations. Toxicol. Lett. 159 (2005) 60-70
55. Sergent T., Ribonnet L., Kolosova A., Garsou S., Schaut A., De Saeger S., Van Peteghem C., Larondelle Y., Pussemier L., and Schneider Y.J. Molecular and cellular effects of food contaminants and secondary plant components and their plausible interactions at the intestinal level. Food Chem. Toxicol. 46 (2008) 813-841
56. Skibola C., and Smith M. Potential health impacts of excessive flavonoid intake. Free Radic. Biol. Med. 29 (2000) 375-383
57. Sohn D., Yun Y.P., Park K., Veech R., and Song B. Posttranslational reduction of cytochrome P450IIE by CCl4, its substrate. Biochem. Biophys. Res. Commun. 179 (1991) 449-454
58. Van der Heiden E., Bechoux N., Muller M., Sergent T., Schneider Y.J., Larondelle Y., Maghuin-Rogister G., and Scippo M.L. Food flavonoid aryl hydrocarbon receptor-mediated agonistic/antagonistic/synergic activities in human and rat reporter gene assays. Anal. Chim. Acta 637 (2009) 337-345
59. Wacher V., Salphati L., and Benet L. Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Del. Rev. 46 (2001) 89-102
60. Walle T. Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass?. Semin. Cancer Biol. 17 (2007) 354-362
61. Walle T., Vincent T., and Walle K. Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells. Biochem. Pharmacol. 65 (2003) 1603-1610
62. Walle K., and Walle T. Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements. Drug Metab. Dispos. 30 (2002) 564-569
63. Wen X., Walle K., and Walle T. 5,7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells. Carcinogenesis 26 (2005) 803-809
64. Xue W., and Warshawsky D. Metabolic activation of polycyclic and hetrocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol. Appl. Pharmacol. 206 (2005) 73-93
65. 3-induced cytochrome P450 3A4 gene expression. Drug Metab. Dispos. 32 (2004) 685-688
66. Zhang S., Qin C., and Safe S. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Environ. Health Perspect. 111 (2003) 1877-1882